Genes for production of the enediyne antitumor antibiotic C-1027 in Streptomyces globisporus are clustered with the cagA gene that encodes the C-1027 apoprotein.

Antimicrobial Agents and Chemotherapy
W Liu, B Shen

Abstract

C-1027, the most potent member of the enediyne antitumor antibiotic family, is produced by Streptomyces globisporus C-1027 and consists of an apoprotein (encoded by the cagA gene) and a nonpeptidic chromophore. The C-1027 chromophore could be viewed as being derived biosynthetically from a benzoxazolinate, a deoxyamino hexose, a beta-amino acid, and an enediyne core. By adopting a strategy for cloning of the C-1027 biosynthesis gene cluster by mapping a putative dNDP-glucose 4,6-dehydratase (NGDH) gene to cagA, we have localized 75 kb of contiguous DNA from S. globisporus. DNA sequence analysis of two regions of the cloned gene cluster revealed two genes, sgcA and sgcB, that encode an NGDH enzyme and a transmembrane efflux protein, respectively, and confirmed that the cagA gene resides approximately 14 kb upstream of the sgcAB locus. The involvement of the cloned gene cluster in C-1027 biosynthesis was demonstrated by disrupting the sgcA gene to generate C-1027-nonproducing mutants and by complementing the sgcA mutants in vivo to restore C-1027 production. These results represent the first cloning of a gene cluster for enediyne antitumor antibiotic biosynthesis and provide a starting point for future genetic and biochemical inv...Continue Reading

References

Oct 1, 1992·Bioscience, Biotechnology, and Biochemistry·N SakataT Otani
Jun 1, 1989·Journal of Bacteriology·P MazodierC Thompson
Aug 1, 1989·The Journal of Antibiotics·Y S ZhenY Yamada
Jan 1, 1987·Methods in Enzymology·R N RaoS Kuhstoss
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·N IkemotoD J Patel
Apr 1, 1994·Bio/technology·C R Hutchinson
Jan 1, 1994·Annual Review of Microbiology·H W Liu, Jon S Thorson
Jan 1, 1993·Annual Review of Microbiology·L Katz, S Donadio
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·H E TakiffW R Jacobs
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·B Shen, C R Hutchinson
Feb 1, 1996·Microbiology·P Matsushima, R H Baltz
Sep 18, 1997·Applied and Environmental Microbiology·P SommerF Götz
Feb 20, 2002·Chemical Reviews·David A. Hopwood

Citations

Sep 30, 2006·Archives of Microbiology·Krzysztof PawlikEriko Takano
Dec 21, 2007·Archives of Microbiology·P Courvalin
Dec 4, 2003·Journal of Biotechnology·T WeberW Wohlleben
Apr 26, 2003·Current Opinion in Chemical Biology·Ben Shen
Apr 30, 2010·Journal of the American Chemical Society·Yinggang LuoBen Shen
Jan 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Steven G Van LanenBen Shen
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Geoff P HorsmanBen Shen
Jan 17, 2009·Cancer Research·Terry A BeermanMary M McHugh
Apr 6, 2007·Biological & Pharmaceutical Bulletin·Fereshteh ShahcheraghiTomofusa Tsuchiya
Nov 28, 2000·Expert Opinion on Investigational Drugs·G M Cragg, D J Newman
Apr 10, 2008·Journal of Internal Medicine·P Courvalin
Feb 24, 2011·Microbial Biotechnology·Carlos OlanoJosé A Salas
Apr 30, 2015·The Journal of Pharmacy and Pharmacology·Christina C AndrosDaniel R Kennedy
Mar 26, 2010·Natural Product Reports·Zhao-Xun Liang
Jan 14, 2017·Genome Announcements·Hisayuki KomakiYasuhiro Igarashi
Jan 19, 2005·World Journal of Gastroenterology : WJG·You-Ping LiuChang-Xiao Liu

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.